1. Home
  2. NBBK vs AORT Comparison

NBBK vs AORT Comparison

Compare NBBK & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBBK

NB Bancorp Inc.

HOLD

Current Price

$20.88

Market Cap

926.5M

Sector

N/A

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$24.28

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBBK
AORT
Founded
1892
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
926.5M
1.1B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
NBBK
AORT
Price
$20.88
$24.28
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$23.50
$49.40
AVG Volume (30 Days)
244.0K
905.2K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
1.43%
N/A
EPS Growth
25.23
165.62
EPS
0.36
0.03
Revenue
N/A
$298,836,000.00
Revenue This Year
$45.15
$14.20
Revenue Next Year
$4.18
$11.20
P/E Ratio
$58.42
$822.00
Revenue Growth
N/A
18.01
52 Week Low
$16.76
$19.16
52 Week High
$22.86
$48.25

Technical Indicators

Market Signals
Indicator
NBBK
AORT
Relative Strength Index (RSI) 54.54 58.01
Support Level $20.11 $19.49
Resistance Level $22.71 $24.70
Average True Range (ATR) 0.49 1.17
MACD 0.03 0.66
Stochastic Oscillator 50.25 82.06

Price Performance

Historical Comparison
NBBK
AORT

About NBBK NB Bancorp Inc.

NB Bancorp Inc operates as the holding company of Needham Bank. The group's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, consumer loans, and other related services.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: